Clinical Staff Scientist, Thermo Fisher Scientific
BIOGRAPHY
Clinical Performance Characteristics of an Molecular IVD-cleared Multiplex Respiratory Panel for SARS-COV-2, influenza A, influenza B, and Respiratory Syncytial Virus with Live Q&A
Speaker
Abstract
Respiratory tract infections caused by multiple pathogens can present overlapping signs, making it challenging to diagnose the cause without targeted, sensitive, molecular testing. In this presentation, Dr. Harita Veereshlingam, a clinical scientist at Thermo Fisher Scientific, will provide an overview of the clinical evaluation results of the TaqPath COVID-19, Flu A, Flu B, RSV Select Panel, a multiplex real-time PCR test designed for the detection and differentiation of SARS‑CoV‑2, influenza A, influenza B, and RSV A/B.
Learning Objectives:
1. Explain the clearance process for an IVD multiplex respiratory panel.
2. Identify the specifications of the IVD multiplex respiratory panel.
3. Summarize the clinical applications of TaqPath COVID-19, Flu A, Flu B, RSV Select Panel.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
APR 21, 2025 | 1:00 PM
C.E. CREDITS
Routine coagulation assays are widely performed in laboratories and provide valuable information to the patient’s overall clinical picture. It’s important for laboratorians to kn...
FEB 25, 2025 | 1:00 PM
C.E. CREDITS
Quality efforts in the clinical laboratory are always under the microscope- a hyper-focus for laboratorians from start to finish. Recognizing the external factors that affect hemostasis test...
APR 02, 2025 | 11:00 AM
Join this year's poster presenters in the Poster Hall during the Poster Networking Hour, Wednesday, September 20th, from 10:00 AM –11:00 AM PDT , to chat live about their posters a...
Loading Comments...